A Study of Electronic Clinical Decision Support Tools for Steatotic Liver Disease

Recruiting now · Not applicable

Conditions studied: MASLD

In brief

The overall objectives of this study are to determine the effectiveness of a participant-specific guided electronic decision support system on provider decision making for participants with metabolic-dysfunction associated steatotic liver disease (MASLD), and to determine the acceptance and barriers for use of an electronic health record embedded algorithm for MASLD care management within ambulatory primary care, endocrinology, and general gastroenterology settings.

Key facts

Study ID

NCT07382349

Run by

Vanderbilt University Medical Center

People needed

7200

Starts

2026-07-20

Expected to finish

2030-02-01

Last updated by the study team

2026-07-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients (age ≥ 18 years)
• Outpatient clinic visit (in-person or telemedicine) at a participating clinic site
• Demonstrated Screening Need due to High Risk Profile, which includes the following: Diagnostic Codes for MASLD or Hepatic Steatosis on Imaging PLUS at least one cardiometabolic risk factors; OR Chronically Elevated Liver Enzymes (> 6 months); OR patient with impaired glycemic control (prediabetes/diabetes); OR 2 or more cardiometabolic risk factors present

You may not qualify if…

• Solid Organ Transplant Recipient
• Existing Hepatology Relationship Evidenced by Prior Hepatology Visit Within 3 Years
• Active Cancer Diagnoses
• Diagnoses for Alcohol-Related Conditions
• Pregnant Individuals
• Receiving Palliative Care Services

Where it is running

• Vanderbilt University Medical Center — Nashville, Tennessee, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.